Whereas previous studies 28,42 have focused on the oncogenic implications of Lin28B-mediated inflammation in hematopoietic cancers, our research emphasizes the broader impact of Lin28A (and probably also Lin28B) dysregulation on inflammatory processes. This evidence concerns the gene LIN28B and hematopoietic and lymphoid cell neoplasm.